Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids

References

• Al-Shabrawey M, Mussell R, Kahook K, Tawfik A, Eladl M, Sarthy V, Nussbaum J, El-Marakby A, Park SY, Gurel Z, et al. 2011. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in Retinal Neovascularization. Diabetes. 60(2):614–624. doi:10.2337/db10-0008.
   PubMed Web of Science ®Google Scholar
• Asakura T, Matsuda M, Matsuda S, Shichi H. 1994. Synthesis of 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by porcine ocular tissues. J Ocul Pharmacol. 10(3):525–535. doi:10.1089/jop.1994.10.525.
   PubMedGoogle Scholar
• Austin Pickens C, Yin Z, Sordillo LM, Fenton JI. 2019. Arachidonic acid-derived hydroxyeicosatetraenoic acids are positively associated with colon polyps in adult males: a cross-sectional study. Sci Rep. 9(1):12033. doi:10.1038/s41598-019-48381-0.
   PubMedGoogle Scholar
• Bacon KB, Camp RD, Cunningham FM, Woollard PM. 1988. Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br J Pharmacol. 95(3):966–974. doi:10.1111/j.1476-5381.1988.tb11727.x.
   PubMed Web of Science ®Google Scholar
• Bednar MM, Gross CE, Balazy MK, Belosludtsev Y, Colella DT, Falck JR, Balazy M. 2000. 16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes. Biochem Pharmacol. 60(3):447–455. doi:10.1016/s0006-2952(00)00345-2.
   PubMed Web of Science ®Google Scholar
• Bednar MM, Gross CE, Russell SR, Fuller SP, Ahern TP, Howard DB, Falck JR, Reddy KM, Balazy M. 2000. 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke. Neurosurgery. 47(6):1410–1419. doi:10.1097/00006123-200012000-00029.
   PubMed Web of Science ®Google Scholar
• Bittleman DB, Casale TB. 1995. 5-Hydroxyeicosatetraenoic acid (HETE)-induced neutrophil transcellular migration is dependent upon enantiomeric structure. Am J Respir Cell Mol Biol. 12(3):260–267. doi:10.1165/ajrcmb.12.3.7873191.
   PubMed Web of Science ®Google Scholar
• Bodnarczuk T, Deskur A, Dolegowska K, Dolegowska B, Starzynska T, Blogowski W. 2018. Hydroxyeicosatetraenoic acids in patients with pancreatic cancer: a preliminary report. Am J Cancer Res. 8(9):1865–1872.
   PubMed Web of Science ®Google Scholar
• Boeglin WE, Kim RB, Brash AR. 1998. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci U S A. 95(12):6744–6749. doi:10.1073/pnas.95.12.6744.
   PubMed Web of Science ®Google Scholar
• Capdevila J, Yadagiri P, Manna S, Falck JR. 1986. Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. Biochem Biophys Res Commun. 141(3):1007–1011. doi:10.1016/s0006-291x(86)80144-9.
   PubMed Web of Science ®Google Scholar
• Capdevila JH, Falck JR, Imig JD. 2007. Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. Kidney Int. 72(6):683–689. doi:10.1038/sj.ki.5002394.
   PubMed Web of Science ®Google Scholar
• Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, McGiff JC. 1996. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol. 271(4 Pt 2):R863–9. doi:10.1152/ajpregu.1996.271.4.R863.
   PubMedGoogle Scholar
• Carroll MA, Garcia MP, Falck JR, McGiff JC. 1992. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J Pharmacol Exp Ther. 260(1):104–109.
   PubMed Web of Science ®Google Scholar
• Ceramella J, Iacopetta D, Franchini A, De Luca M, Saturnino C, Andreu I, Sinicropi MS, Catalano A. 2022. A Look at the Importance of Chirality in Drug Activity: some Significative Examples. Appl Sci. 12(21):10909. doi:10.3390/app122110909.
   Google Scholar
• Chadderdon SM, Belcik JT, Bader L, Kievit P, Grove KL, Lindner JR. 2016. Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates. Int J Obes. 40(10):1600–1603. doi:10.1038/ijo.2016.117.
   Web of Science ®Google Scholar
• Chang J, Blazek E, Kreft AF, Lewis AJ. 1985. Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs) A novel pharmacological mechanism for regulating free fatty acid release. Biochem Pharmacol. 34(9):1571–1575. doi:10.1016/0006-2952(85)90701-4.
   PubMed Web of Science ®Google Scholar
• Cheng J, Ou J-S, Singh H, Falck JR, Narsimhaswamy D, Pritchard KA, Schwartzman ML.Jr. 2008. 20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling. Am J Physiol Heart Circ Physiol. 294(2):H1018–26. doi:10.1152/ajpheart.01172.2007.
   PubMed Web of Science ®Google Scholar
• Chiaro CR, Patel RD, Perdew GH. 2008. 12(R)-Hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of the aryl hydrocarbon receptor. Mol Pharmacol. 74(6):1649–1656. doi:10.1124/mol.108.049379.
   PubMed Web of Science ®Google Scholar
• Cioccari L, Luethi N, Duong T, Ryan E, Cutuli SL, Lloyd-Donald P, Eastwood GM, Peck L, Young H, Vaara ST, et al. 2020. Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial. Critical Care Resuscitation J Austral Acad Crit Care Med. 22(3):227–236. doi:10.1016/S1441-2772(23)00390-3.
   Web of Science ®Google Scholar
• Cunningham FM, Woollard PM. 1987. 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro. Prostaglandins. 34(1):71–78. doi:10.1016/0090-6980(87)90264-4.
   PubMedGoogle Scholar
• Dakarapu R, Errabelli R, Manthati VL, Michael Adebesin A, Barma DK, Barma D, Garcia V, Zhang F, Laniado Schwartzman M, Falck JR. 2019. 19-Hydroxyeicosatetraenoic acid analogs: antagonism of 20-hydroxyeicosatetraenoic acid-induced vascular sensitization and hypertension. Bioorg Med Chem Lett. 29(19):126616. doi:10.1016/j.bmcl.2019.08.020.
   PubMed Web of Science ®Google Scholar
• Damon M, Chavis C, Daures JP, Crastes de Paulet A, Michel FB, Godard P. 1989. Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium. Eur Respir J. 2(3):202–209. doi:10.1183/09031936.93.02030202.
   PubMed Web of Science ®Google Scholar
• Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. 1999. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 261(1):218–223. doi:10.1006/bbrc.1999.1012.
   PubMed Web of Science ®Google Scholar
• Ding X-Z, Tong W-G, Adrian TE. 2001. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int J Cancer. 94(5):630–636. doi:10.1002/ijc.1527.
   PubMed Web of Science ®Google Scholar
• Ding XZ, Tong WG, Adrian TE. 2003. Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer. Oncology. 65(4):285–294. doi:10.1159/000074640.
   PubMed Web of Science ®Google Scholar
• Elkhatali S, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, El-Kadi AO. 2015. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy. Toxicol Appl Pharmacol. 289(3):550–559. doi:10.1016/j.taap.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Elkhatali S, Maayah ZH, El-Sherbeni AA, Elshenawy OH, Abdelhamid G, Shoieb SM, El-Kadi AOS. 2017. Inhibition of mid-chain HETEs protects against angiotensin II-induced cardiac hypertrophy. J Cardiovasc Pharmacol. 70(1):16–24. doi:10.1097/FJC.0000000000000494.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AO. 2014. Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As. Drug Metab Dispos. 42(9):1498–1507. doi:10.1124/dmd.114.057836.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AO. 2016. Repurposing resveratrol and fluconazole to modulate human cytochrome P450-mediated arachidonic acid metabolism. Mol Pharm. 13(4):1278–1288. doi:10.1021/acs.molpharmaceut.5b00873.
   PubMedGoogle Scholar
• Escalante B, Falck JR, Yadagiri P, Sun L, Laniado-Schwartzman M. 1988. 19(S)-hydroxyeicosatetraenoic acid is a potent stimulator of renal Na+-K+-ATPase. Biochem Biophys Res Commun. 152(3):1269–1274. doi:10.1016/s0006-291x(88)80422-4.
   PubMed Web of Science ®Google Scholar
• Esteves F, Rueff J, Kranendonk M. 2021. The central role of cytochrome P450 in xenobiotic metabolism-a brief review on a fascinating enzyme family. J Xenobiot. 11(3):94–114. doi:10.3390/jox11030007.
   PubMed Web of Science ®Google Scholar
• Faraci FM, Sobey CG, Chrissobolis S, Lund DD, Heistad DD, Weintraub NL. 2001. Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K(+) channels. Am J Physiol Regul Integr Comp Physiol. 281(1):R246–53. doi:10.1152/ajpregu.2001.281.1.R246.
   PubMed Web of Science ®Google Scholar
• Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN. 2003. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 Inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells 1. J Immunol. 170(5):2688–2694. doi:10.4049/jimmunol.170.5.2688.
   PubMed Web of Science ®Google Scholar
• Gal J. 2011. Louis Pasteur, language, and molecular chirality. I. Background and dissymmetry. Chirality. 23(1):1–16. doi:10.1002/chir.20866.
   PubMed Web of Science ®Google Scholar
• Gerges SH, Alammari AH, El-Ghiaty MA, Isse FA, El-Kadi AOS. 2023. Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs. Can J Physiol Pharmacol. 101(8):425–436. doi:10.1139/cjpp-2023-0014.
   PubMedGoogle Scholar
• Ghosh J, Myers CE. 1998. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A. 95(22):13182–13187. doi:10.1073/pnas.95.22.13182.
   PubMed Web of Science ®Google Scholar
• Gong Y, Ni X, Jin C, Li X, Wang Y, Wang O, Li M, Xing X, Wu Z, Jiang Y, et al. 2022. Serum metabolomics reveals dysregulation and diagnostic potential of oxylipins in tumor-induced osteomalacia. J Clin Endocrinol Metab. 107(5):1383–1391. doi:10.1210/clinem/dgab885.
   PubMed Web of Science ®Google Scholar
• González-Núñez D, Claria J, Rivera F, Poch E. 2001. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension. 37(2):334–338. doi:10.1161/01.hyp.37.2.334.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly A-K, Hsu A, Zhou S, Maddipati KR, Liu J, et al. 2011. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem. 286(39):33832–33840. doi:10.1074/jbc.M110.216564.
   PubMed Web of Science ®Google Scholar
• H. Brooks W, C. Guida W, G. Daniel K. 2011. The significance of chirality in drug design and development. Curr Top Med Chem. 11(7):760–770. doi:10.2174/156802611795165098.
   PubMed Web of Science ®Google Scholar
• Hampson AJ, Grimaldi M. 2002. 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J Neurosci. 22(1):257–264. doi:10.1523/JNEUROSCI.22-01-00257.2002.
   PubMed Web of Science ®Google Scholar
• Hao CM, Breyer MD. 2007. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 71(11):1105–1115. doi:10.1038/sj.ki.5002192.
   PubMed Web of Science ®Google Scholar
• Henrich WL, Falck JR, Campbell WB. 1992. Inhibition of renin secretion from rat renal cortical slices by (R)-12-HETE. Am J Physiol. 263(4 Pt 2):F665–70. doi:10.1152/ajprenal.1992.263.4.F665.
   PubMedGoogle Scholar
• Heydeck D, Ufer C, Kakularam KR, Rothe M, Liehr T, Poulain P, Kuhn H. 2023. Functional characterization of transgenic mice overexpressing human 15-lipoxygenase-1 (ALOX15) under the control of the aP2 promoter. IJMS. 24(5):4815. doi:10.3390/ijms24054815.
   Google Scholar
• Hidayat R, Shoieb SM, Mosa FES, Barakat K, Brocks DR, Isse FA, Gerges SH, El-Kadi AOS. 2023. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism. Mol Cell Biochem. doi:10.1007/s11010-023-04801-4. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Honn KV, Tang DG, Grossi IM, Renaud C, Duniec ZM, Johnson CR, Diglio CA. 1994. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res. 210(1):1–9. doi:10.1006/excr.1994.1001.
   PubMed Web of Science ®Google Scholar
• Hsu T, Nguyen-Tran HH, Trojanowska M. 2019. Active roles of dysfunctional vascular endothelium in fibrosis and cancer. J Biomed Sci. 26(1):86. doi:10.1186/s12929-019-0580-3.
   PubMed Web of Science ®Google Scholar
• Huang C-C, Chang M-T, Leu H-B, Yin W-H, Tseng W-K, Wu Y-W, Lin T-H, Yeh H-I, Chang K-C, Wang J-H, et al. 2020. Association of arachidonic acid-derived lipid mediators with subsequent onset of acute myocardial infarction in patients with coronary artery disease. Sci Rep. 10(1):8105. doi:10.1038/s41598-020-65014-z.
   PubMed Web of Science ®Google Scholar
• Isse FA, Alammari AH, El-Sherbeni AA, Brocks DR, El-Kadi AOS. 2023. The enantioselective separation and quantitation of the hydroxy-metabolites of arachidonic acid by liquid chromatography – tandem mass spectrometry. Prostaglandins Other Lipid Mediat. 165:106701. doi:10.1016/j.prostaglandins.2022.106701.
   PubMed Web of Science ®Google Scholar
• Isse FA, Alammari AH, El-Sherbeni AA, El-Kadi AOS. 2023. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners. Prostaglandins Other Lipid Mediat. 168:106749. doi:10.1016/j.prostaglandins.2023.106749.
   PubMed Web of Science ®Google Scholar
• Jenkins CM, Cedars A, Gross RW. 2008. Eicosanoid signalling pathways in the heart. Cardiovasc Res. 82(2):240–249. doi:10.1093/cvr/cvn346.
   PubMed Web of Science ®Google Scholar
• Kain V, Ingle KA, Kabarowski J, Barnes S, Limdi NA, Prabhu SD, Halade GV. 2018. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction. J Mol Cell Cardiol. 118:70–80. doi:10.1016/j.yjmcc.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Kandouz M, Nie D, Pidgeon GP, Krishnamoorthy S, Maddipati KR, Honn KV. 2003. Platelet-type 12-lipoxygenase activates NF-κB in prostate cancer cells. Prostaglandins Other Lipid Mediat. 71(3-4):189–204. doi:10.1016/s1098-8823(03)00042-x.
   PubMed Web of Science ®Google Scholar
• Kang K-H, Ling T-Y, Liou H-H, Huang Y-K, Hour M-J, Liou H-C, Fu W-M. 2013. Enhancement role of host 12/15-lipoxygenase in melanoma progression. Eur J Cancer. 49(12):2747–2759. doi:10.1016/j.ejca.2013.03.030.
   PubMed Web of Science ®Google Scholar
• Kayama Y, Minamino T, Toko H, Sakamoto M, Shimizu I, Takahashi H, Okada S, Tateno K, Moriya J, Yokoyama M, et al. 2009. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med. 206(7):1565–1574. doi:10.1084/jem.20082596.
   PubMed Web of Science ®Google Scholar
• Kenne E, Erlandsson A, Lindbom L, Hillered L, Clausen F. 2012. Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. J Neuroinflammation. 9(1):17. doi:10.1186/1742-2094-9-17.
   PubMedGoogle Scholar
• Kim D-K, Kim H-J, Sung K-S, Kim H, Cho S-A, Kim K-M, Lee C-H, Kim J-J. 2007. 12(S)-HPETE induces itch-associated scratchings in mice. Eur J Pharmacol. 554(1):30–33. doi:10.1016/j.ejphar.2006.09.057.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim DK, Kim H, Koh JY, Kim KM, Noh MS, Lee S, Kim S, Park SH, Kim JJ, et al. 2008. Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice. Br J Pharmacol. 154(5):1073–1078. doi:10.1038/bjp.2008.220.
   PubMed Web of Science ®Google Scholar
• Krieg P, Rosenberger S, de Juanes S, Latzko S, Hou J, Dick A, Kloz U, van der Hoeven F, Hausser I, Esposito I, et al. 2013. Aloxe3 knockout mice reveal a function of epidermal lipoxygenase-3 as hepoxilin synthase and its pivotal role in barrier formation. J Invest Dermatol. 133(1):172–180. doi:10.1038/jid.2012.250.
   PubMed Web of Science ®Google Scholar
• Laethem R, Balazy M, Falck J, Laethem C, Koop D. 1993. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem. 268(17):12912–12918. doi:10.1016/S0021-9258(18)31472-8.
   PubMed Web of Science ®Google Scholar
• Lapuerta L, Chacos N, Falck JR, Jacobson H, Capdevila JH. 1988. Renal microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Am J Med Sci. 295(4):275–279. doi:10.1097/00000441-198804000-00010.
   PubMed Web of Science ®Google Scholar
• Liu B, Khan WA, Hannun YA, Timar J, Taylor JD, Lundy S, Butovich I, Honn KV. 1995. 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc Natl Acad Sci U S A. 92(20):9323–9327. doi:10.1073/pnas.92.20.9323.
   PubMed Web of Science ®Google Scholar
• Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ. 1993. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res. 72(1):126–136. doi:10.1161/01.res.72.1.126.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, Abdelhamid G, El-Kadi AO. 2015. Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB. Cell Biol Toxicol. 31(4-5):241–259. doi:10.1007/s10565-015-9308-7.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, Althurwi HN, Abdelhamid G, Lesyk G, Jurasz P, El-Kadi AO. 2016. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism. Pharmacol Res. 105:28–43. doi:10.1016/j.phrs.2015.12.016.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, Althurwi HN, El-Sherbeni AA, Abdelhamid G, Siraki AG, El-Kadi AO. 2017. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem. 429(1-2):151–165. doi:10.1007/s11010-017-2943-y.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, El-Kadi AO. 2016. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy. Arch Toxicol. 90(1):119–136. doi:10.1007/s00204-015-1620-8.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, Levasseur J, Siva Piragasam R, Abdelhamid G, Dyck JRB, Fahlman RP, Siraki AG, El-Kadi AOS. 2018. 2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy. Sci Rep. 8(1):2780. doi:10.1038/s41598-018-20613-9.
   PubMedGoogle Scholar
• Masferrer J, Mullane KM. 1988. Modulation of vascular tone by 12(R)-, but not 12(S)-, hydroxyeicosatetraenoic acid. Eur J Pharmacol. 151(3):487–490. doi:10.1016/0014-2999(88)90549-3.
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Rios AP, Schwartzman ML. 1990. Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid. Biochem Pharmacol. 39(12):1971–1974. doi:10.1016/0006-2952(90)90617-t.
   PubMed Web of Science ®Google Scholar
• Mazaleuskaya LL, Salamatipour A, Sarantopoulou D, Weng L, FitzGerald GA, Blair IA, Mesaros C. 2018. Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS. J Lipid Res. 59(3):564–575. doi:10.1194/jlr.D081414.
   PubMed Web of Science ®Google Scholar
• McCarty MF. 2004. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. Integr Cancer Ther. 3(4):349–380. doi:10.1177/1534735404270757.
   PubMedGoogle Scholar
• McDonnell AM, Dang CH. 2013. Basic review of the cytochrome p450 system. J Adv Pract Oncol. 4(4):263–268. doi:10.6004/jadpro.2013.4.4.7.
   PubMedGoogle Scholar
• Miller AW, Katakam PV, Lee HC, Tulbert CD, Busija DW, Weintraub NL. 2003. Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent. J Pharmacol Exp Ther. 304(1):139–144. doi:10.1124/jpet.102.041780.
   PubMed Web of Science ®Google Scholar
• Nagata N, Hamasaki Y, Inagaki S, Nakamura T, Horikami D, Yamamoto-Hanada K, et al. 2021. Urinary lipid profile of atopic dermatitis in murine model and human patients. FASEB J. 35(11):e21949.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Reddy MA. 2003. HETEs/EETs in renal glomerular and epithelial cell functions. Curr Opin Pharmacol. 3(2):198–203. doi:10.1016/s1471-4892(03)00015-8.
   PubMed Web of Science ®Google Scholar
• Nazarewicz RR, Zenebe WJ, Parihar A, Parihar MS, Vaccaro M, Rink C, Sen CK, Ghafourifar P. 2007. 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys. 468(1):114–120. doi:10.1016/j.abb.2007.09.018.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. 2006. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 6(12):947–960. doi:10.1038/nrc2015.
   PubMed Web of Science ®Google Scholar
• Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, Zacharek A, Guo Y, Milanini J, Pages G, et al. 2006. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem. 281(27):18601–18609. doi:10.1074/jbc.M601887200.
   PubMed Web of Science ®Google Scholar
• Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K, Tang K, Hillman GG, Cher ML, Grignon DJ, et al. 2003. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis. 20(7):657–663. doi:10.1023/a:1027302408187.
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, Isbell MA, See WA, Campbell WB. 2006. Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases. Cancer Lett. 233(2):219–225. doi:10.1016/j.canlet.2005.03.025.
   PubMed Web of Science ®Google Scholar
• O'Flaherty JT, Thomas MJ, Lees CJ, McCall CE. 1981. Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am J Pathol. 104(1):55–62.
   PubMed Web of Science ®Google Scholar
• Parmentier JH, Muthalif MM, Saeed AE, Malik KU. 2001. Phospholipase D activation by norepinephrine is mediated by 12(s)-, 15(s)-, and 20-hydroxyeicosatetraenoic acids generated by stimulation of cytosolic phospholipase a2. tyrosine phosphorylation of phospholipase d2 in response to norepinephrine. J Biol Chem. 276(19):15704–15711. doi:10.1074/jbc.M011473200.
   PubMed Web of Science ®Google Scholar
• Pickens CA, Sordillo LM, Zhang C, Fenton JI. 2017. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE). Metabolism. 70:177–191. doi:10.1016/j.metabol.2017.01.034.
   PubMed Web of Science ®Google Scholar
• Powell WS, Gravelle F, Gravel S. 1992. Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J Biol Chem. 267(27):19233–19241. doi:10.1016/S0021-9258(18)41766-8.
   PubMed Web of Science ®Google Scholar
• Powell WS, Rokach J. 2015. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta. 1851(4):340–355. doi:10.1016/j.bbalip.2014.10.008.
   PubMed Web of Science ®Google Scholar
• Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ. 2007. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 46(4):1081–1090. doi:10.1002/hep.21763.
   PubMed Web of Science ®Google Scholar
• Quigley R, Baum M, Reddy KM, Griener JC, Falck JR. 2000. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am J Physiol Renal Physiol. 278(6):F949–53. doi:10.1152/ajprenal.2000.278.6.F949.
   PubMed Web of Science ®Google Scholar
• Quilley CP, McGiff JC. 1990. Isomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid reduce renin activity and increase water and electrolyte excretion. J Pharmacol Exp Ther. 254(3):774–780.
   PubMed Web of Science ®Google Scholar
• Quintana LF, Guzmán B, Collado S, Clària J, Poch E. 2006. A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE. Kidney Int. 69(3):526–530. doi:10.1038/sj.ki.5000147.
   PubMed Web of Science ®Google Scholar
• Radeau T, Chavis C, Damon M, Michel FB, De Paulet AC, Godard PH. 1990. Enhanced arachidonic acid metabolism and human neutrophil migration in asthma. Prostaglandins Leukot Essent Fatty Acids. 41(2):131–138. doi:10.1016/0952-3278(90)90066-t.
   PubMed Web of Science ®Google Scholar
• Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, Natarajan R. 2002. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem. 277(12):9920–9928. doi:10.1074/jbc.M111305200.
   PubMed Web of Science ®Google Scholar
• Reddy YK, Reddy LM, Capdevila JH, Falck JR. 2003. Practical, asymmetric synthesis of 16-hydroxyeicosa-5(Z),8(Z), 11(Z),14(Z)-tetraenoic acid (16-HETE), an endogenous inhibitor of neutrophil activity. Bioorg Med Chem Lett. 13(21):3719–3720. doi:10.1016/j.bmcl.2003.08.005.
   PubMed Web of Science ®Google Scholar
• Sacerdoti D, Gatta A, McGiff JC. 2003. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Other Lipid Mediat. 72(1-2):51–71. doi:10.1016/s1098-8823(03)00077-7.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Hori MT, Hino T, Golub MS, Tuck ML. 1997. Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypert. 10(4):371–378. doi:10.1016/S0895-7061(97)90519-7.
   PubMed Web of Science ®Google Scholar
• Schwartzman ML, Balazy M, Masferrer J, Abraham NG, McGiff JC, Murphy RC. 1987. 12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A. 84(22):8125–8129. doi:10.1073/pnas.84.22.8125.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, Dakarapu R, Falck JR, El-Kadi AOS. 2021. Novel synthetic analogues of 19(S/R)-hydroxyeicosatetraenoic acid exhibit noncompetitive inhibitory effect on the activity of cytochrome P450 1A1 and 1B1. Eur J Drug Metab Pharmacokinet. 46(5):613–624. doi:10.1007/s13318-021-00699-9.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, El-Kadi AOS. 2018. S-Enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy. Drug Metab Dispos. 46(8):1157–1168. doi:10.1124/dmd.118.082073.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, El-Kadi AOS. 2020. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites. Mol Cell Biochem. 471(1-2):165–176. doi:10.1007/s11010-020-03777-9.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, El-Sherbeni AA, El-Kadi AOS. 2019. Identification of 19-(S/R)hydroxyeicosatetraenoic acid as the first endogenous noncompetitive inhibitor of cytochrome P450 1B1 with enantioselective activity. Drug Metab Dispos. 47(2):67–70. doi:10.1124/dmd.118.084657.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, El-Sherbeni AA, El-Kadi AOS. 2019. Subterminal hydroxyeicosatetraenoic acids: crucial lipid mediators in normal physiology and disease states. Chem Biol Interact. 299:140–150. doi:10.1016/j.cbi.2018.12.004.
   PubMed Web of Science ®Google Scholar
• Siangjong L, Gauthier KM, Pfister SL, Smyth EM, Campbell WB. 2013. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries. Am J Physiol Heart Circ Physiol. 304(3):H382–92. doi:10.1152/ajpheart.00690.2012.
   PubMed Web of Science ®Google Scholar
• Singh NK, Kundumani-Sridharan V, Rao GN. 2011. 12/15-Lipoxygenase gene knockout severely impairs ischemia-induced angiogenesis due to lack of Rac1 farnesylation. Blood. 118(20):5701–5712. doi:10.1182/blood-2011-04-347468.
   PubMed Web of Science ®Google Scholar
• Singh NK, Rao GN. 2019. Emerging role of 12/15-lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res. 73:28–45. doi:10.1016/j.plipres.2018.11.001.
   PubMed Web of Science ®Google Scholar
• Soumya SJ, Binu S, Helen A, Anil Kumar K, Reddanna P, Sudhakaran PR. 2012. Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic. Inflamm Res. 61(7):707–718. doi:10.1007/s00011-012-0463-5.
   PubMed Web of Science ®Google Scholar
• Soumya SJ, Binu S, Helen A, Reddanna P, Sudhakaran PR. 2013. 15(S)-HETE-induced angiogenesis in adipose tissue is mediated through activation of PI3K/Akt/mTOR signaling pathway. Biochem Cell Biol. 91(6):498–505. doi:10.1139/bcb-2013-0037.
   PubMed Web of Science ®Google Scholar
• Stern N, Kisch ES, Knoll E. 1996. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension. 27(5):1149–1152. doi:10.1161/01.hyp.27.5.1149.
   PubMed Web of Science ®Google Scholar
• Takai S, Jin D, Hara K, Takami H, Fujita T, Miyazaki M. 1998. 12-Hydroxyeicosatetraenoic acid directly potentiates angiotensin II-induced vascular contraction. Eur J Pharmacol. 358(2):161–164. doi:10.1016/s0014-2999(98)00610-4.
   PubMed Web of Science ®Google Scholar
• Takai S, Jin D, Kirimura K, Fujimoto Y, Miyazaki M. 2001. 12-Hydroxyeicosatetraenoic acid potentiates angiotensin II-induced pressor response in rats. Eur J Pharmacol. 418(1-2):R1–R2. doi:10.1016/s0014-2999(01)00935-9.
   PubMed Web of Science ®Google Scholar
• Tang DG, Renaud C, Stojakovic S, Diglio CA, Porter A, Honn KV. 1995. 12(S)-HETE Is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun. 211(2):462–468. doi:10.1006/bbrc.1995.1836.
   PubMed Web of Science ®Google Scholar
• Tang DG, Tarrien M, Dobrzynski P, Honn KV. 1995. Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK). J Cell Physiol. 165(2):291–306. doi:10.1002/jcp.1041650210.
   PubMed Web of Science ®Google Scholar
• Tímár J, Hegedüs B, Rásó E. 2018. The role of lipid signaling in the progression of malignant melanoma. Cancer Metastasis Rev. 37(2-3):245–255. doi:10.1007/s10555-018-9729-x.
   PubMed Web of Science ®Google Scholar
• Timar J, Tang D, Bazaz R, Haddad MM, Kimler VA, Taylor JD, Honn KV. 1993. PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells. Cell Motil Cytoskeleton. 26(1):49–65. doi:10.1002/cm.970260106.
   PubMed Web of Science ®Google Scholar
• Tsao CC, Foley J, Coulter SJ, Maronpot R, Zeldin DC, Goldstein JA. 2000. CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. Mol Pharmacol. 58(2):279–287. doi:10.1124/mol.58.2.279.
   PubMed Web of Science ®Google Scholar
• Tunaru S, Chennupati R, Nüsing RM, Offermanns S. 2016. Arachidonic acid metabolite 19(S)-HETE induces vasorelaxation and platelet inhibition by activating prostacyclin (IP) receptor. PLoS One. 11(9):e0163633. doi:10.1371/journal.pone.0163633.
   PubMed Web of Science ®Google Scholar
• Van Doren L, Nguyen N, Garzia C, Fletcher EK, Stevenson R, Jaramillo D, Kuliopulos A, Covic L. 2021. Lipid receptor GPR31 (G-Protein–Coupled Receptor 31) regulates platelet reactivity and thrombosis without affecting hemostasis. Arterioscler Thromb Vasc Biol. 41(1):e33–e45. doi:10.1161/ATVBAHA.120.315154.
   PubMed Web of Science ®Google Scholar
• Vantomme G, Crassous J. 2021. Pasteur and chirality: a story of how serendipity favors the prepared minds. Chirality. 33(10):597–601. doi:10.1002/chir.23349.
   PubMed Web of Science ®Google Scholar
• Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo TPN, Madlener S, Bauer S, et al. 2011. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer. 105(2):263–271. doi:10.1038/bjc.2011.194.
   PubMed Web of Science ®Google Scholar
• Wallukat G, Morwinski R, Kühn H. 1994. Modulation of the beta-adrenergic response of cardiomyocytes by specific lipoxygenase products involves their incorporation into phosphatidylinositol and activation of protein kinase C. J Biol Chem. 269(46):29055–29060. doi:10.1016/S0021-9258(19)62012-0.
   PubMed Web of Science ®Google Scholar
• Wang T, Fu X, Chen Q, Patra JK, Wang D, Wang Z, Gai Z. 2019. Arachidonic acid Metabolism and kidney inflammation. Int J Mol Sci. 20(15):3683. doi:10.3390/ijms20153683.
   PubMed Web of Science ®Google Scholar
• Wen Y, Gu J, Vandenhoff G, Liu X, Nadler J. 2008. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am J Physiol Heart Circ Physiol. 294(4):H1933–8. doi:10.1152/ajpheart.00260.2007.
   PubMed Web of Science ®Google Scholar
• Wiggins RE, Jafri MS, Proia AD. 1990. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent nutrophil chemoattractant than the 12(E) epimer in the rat cornea. Prostaglandins. 40(2):131–141. doi:10.1016/0090-6980(90)90079-b.
   PubMedGoogle Scholar
• Xu J, Jin L, Sun Y, Zhang R, Chen X, Zhou R, Gu Y, Hu C. 2022. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline. Diabetes Metab Res Rev. 38(6):e3554. doi:10.1002/dmrr.3554.
   PubMed Web of Science ®Google Scholar
• Yamada M, Proia AD. 2000. 8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea. Cornea. 19(3 Suppl):S13–S20. doi:10.1097/00003226-200005001-00004.
   PubMed Web of Science ®Google Scholar
• Zeng ZZ, Yellaturu CR, Neeli I, Rao GN. 2002. 5(S)-hydroxyeicosatetraenoic acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and phosphatidylinositol 3-kinase/Akt signaling, leading to induction of expression of basic fibroblast growth factor 2. J Biol Chem. 277(43):41213–41219. doi:10.1074/jbc.M204508200.
   PubMed Web of Science ®Google Scholar
• Zhang F, Deng H, Kemp R, Singh H, Gopal VR, Falck JR, Laniado-Schwartzman M, Nasjletti A. 2005. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats. Hypertension. 45(1):103–108. doi:10.1161/01.HYP.0000150782.28485.91.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang S, Huang Y, Yang K, Liu Y, Bi X, et al. 2020. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin. Mol Med Rep. 21(1):393–404.
   PubMed Web of Science ®Google Scholar
• Zhao T, Wang D, Cheranov SY, Karpurapu M, Chava KR, Kundumani-Sridharan V, Johnson DA, Penn JS, Rao GN. 2009. A novel role for activating transcription factor-2 in 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis. J Lipid Res. 50(3):521–533. doi:10.1194/jlr.M800388-JLR200.
   PubMed Web of Science ®Google Scholar
• Zink MH, Oltman CL, Lu T, Katakam PV, Kaduce TL, Lee H, Dellsperger KC, Spector AA, Myers PR, Weintraub NL, et al. 2001. 12-lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation. Am J Physiol Heart Circ Physiol. 280(2):H693–704. doi:10.1152/ajpheart.2001.280.2.H693.
   PubMed Web of Science ®Google Scholar
• Zordoky BNM, El-Kadi AOS. 2010. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther. 125(3):446–463. doi:10.1016/j.pharmthera.2009.12.002.
   PubMed Web of Science ®Google Scholar